Feed - News and features

• Novo partners with Hims & Hers again, ending GLP-1 spat
  Novo Nordisk and Hims & Hers have...
• Incyte breaks new ground in anal cancer with EU approval
  Incyte claims EU approval for Zynyz as...
• Alfasigma licenses liver drug from GSK in $590m deal
  With an FDA verdict looming, GSK has...
• Roche's oral SERD flunks phase 3 breast cancer test
  Roche's recent run of positive study...

News | PharmaTimes

• Lundbeck completes patient randomisation early in global MSA trial
• Incyte treatment for advanced anal cancer approved in Europe
• HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
• Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
• AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays

• Implementation Outcomes and Cost-effectiveness of Developmental Monitoring for Children Exposed to HIV
• REal-world Valued Outcomes of a noveL Balloon-in-basket pUlsed Field ablaTION Catheter for Atrial Fibrillation RegistrY
• Comparative Effects of Spencer Techniques and Movement With Mobilization in Improving Pain, Range of Motion, and Functional Disability in Rotator Cuff Syndrome.
• Effect of Nature Sounds During Dental Filling on Anxiety in Older Adults